Maria Bloksgaard

Dr. Maria Bloksgaard

The Research Unit of Cardiovascular and Renal Research, Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDF file
IIIchiro Iwai
Ichiro Iwai
HHHongMei Han
HongMei Han
LHLianne Den Hollander
Lianne Den Hollander
SSStina Svensson
Stina Svensson
LÖLars-Göran Öfverstedt
Lars-Göran Öfverstedt
LNLars Norlén
Lars Norlén
The skin barrier is fundamental to terrestrial life and its evolution; it upholds homeostasis and protects against the environment. Skin barrier capacity is controlled by lipids that fill the extracellular space of the skin's surface layer—the stratum corneum. Here we report on the determination of the molecular organization of the skin's lipid matrix in situ, in its near-native state, using a methodological approach combining very high magnification cryo-electron microscopy (EM) of vitreous skin section defocus series, molecular modeling, and EM simulation. The lipids are organized in an arrangement not previously described in a biological system—stacked bilayers of fully extended ceramides (CERs) with cholesterol molecules associated with the CER sphingoid moiety. This arrangement rationalizes the skin's low permeability toward water and toward hydrophilic and lipophilic substances, as well as the skin barrier's robustness toward hydration and dehydration, environmental temperature and pressure changes, stretching, compression, bending, and shearing.

1 January 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SCStefania Carobbio
Stefania Carobbio
FFFrancesca Frigerio
Francesca Frigerio
BRBlanca Rubi
Blanca Rubi
LVLauréne Vetterli
Lauréne Vetterli
Maria BloksgaardMaria Bloksgaard
Maria Bloksgaard
PMPierre Maechler
Pierre Maechler
Insulin exocytosis is regulated in pancreatic ss-cells by a cascade of intracellular signals translating glucose levels into corresponding secretory responses. The mitochondrial enzyme glutamate dehydrogenase (GDH) is regarded as a major player in this process, although its abrogation has not been tested yet in animal models. Here, we generated transgenic mice, named betaGlud1(-/-), with ss-cell-specific GDH deletion. Our results show that GDH plays an essential role in the full development of the insulin secretory response. In situ pancreatic perfusion revealed that glucose-stimulated insulin secretion was reduced by 37% in betaGlud1(-/-). Furthermore, isolated islets with either constitutive or acute adenovirus-mediated knock-out of GDH showed a 49 and 38% reduction in glucose-induced insulin release, respectively. Adenovirus-mediated re-expression of GDH in betaGlud1(-/-) islets fully restored glucose-induced insulin release. Thus, GDH appears to account for about 40% of glucose-stimulated insulin secretion and to lack redundant mechanisms. In betaGlud1(-/-) mice, the reduced secretory capacity resulted in lower plasma insulin levels in response to both feeding and glucose load, while body weight gain was preserved. The results demonstrate that GDH is essential for the full development of the secretory response in beta-cells. However, maximal secretory capacity is not required for maintenance of glucose homeostasis in normo-caloric conditions.

1 May 2013 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JBJonathan Richard Brewer
Jonathan Richard Brewer
Maria BloksgaardMaria Bloksgaard
Maria Bloksgaard
JKJakub Kubiak
Jakub Kubiak
JSJens Ahm Sørensen
Jens Ahm Sørensen
LBLuis A. Bagatolli
Luis A. Bagatolli

1 February 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DNDitte Neess
Ditte Neess
Maria BloksgaardMaria Bloksgaard
Maria Bloksgaard
SBSigne Bek
Signe Bek
AMAnn-Britt Marcher
Ann-Britt Marcher
IEIda C. Elle
Ida C. Elle
SMSusanne Mandrup
Susanne Mandrup
The acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor is an intracellular protein that binds C(14)-C(22) acyl-CoA esters and is thought to act as an acyl-CoA transporter. In vitro analyses have indicated that ACBP can transport acyl-CoA esters between different enzymatic systems; however, little is known about the in vivo function in mammalian cells. We have generated mice with targeted disruption of ACBP (ACBP(-/-)). These mice are viable and fertile and develop normally. However, around weaning, the ACBP(-/-) mice go through a crisis with overall weakness and a slightly decreased growth rate. Using microarray analysis, we show that the liver of ACBP(-/-) mice displays a significantly delayed adaptation to weaning with late induction of target genes of the sterol regulatory element-binding protein (SREBP) family. As a result, hepatic de novo cholesterogenesis is decreased at weaning. The delayed induction of SREBP target genes around weaning is caused by a compromised processing and decreased expression of SREBP precursors, leading to reduced binding of SREBP to target sites in chromatin. In conclusion, lack of ACBP interferes with the normal metabolic adaptation to weaning and leads to delayed induction of the lipogenic gene program in the liver.

29 May 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
BBBo Bai
Bo Bai
AMAndy W. C. Man
Andy W. C. Man
KYKangmin Yang
Kangmin Yang
YGYumeng Guo
Yumeng Guo
CXCheng Xu
Cheng Xu
YWYu Wang
Yu Wang
Endothelial SIRT1 prevents adverse arterial remodeling by facilitating HERC2-mediated degradation of acetylated LKB1

1 December 2013 in Cell Reports
Verified
Journal Article
Open access
DNDitte Neess
Ditte Neess
SBSigne Bek
Signe Bek
Maria BloksgaardMaria Bloksgaard
Maria Bloksgaard
AMAnn-Britt Marcher
Ann-Britt Marcher
Nils FærgemanNils Færgeman
Nils Færgeman
SMSusanne Mandrup
Susanne Mandrup
We previously reported that mice deficient in acyl-CoA-binding protein (ACBP) display a delayed metabolic adaptation to weaning. This includes a delayed activation of the hepatic lipogenic gene program, which may result from hepatic accumulation of triacylglycerol and/or cholesteryl esters in the late suckling period. To further investigate the basis for this phenotype, we generated mice deficient in ACBP in hepatocytes (Alb-ACBP(-/-)) and keratinocytes (K14-ACBP(-/-)). Surprisingly, the delayed adaptation to weaning, including hepatic lipid accumulation, is caused by ACBP deficiency in the skin rather than in the liver. Similarly to ACBP(-/-) mice, K14-ACBP(-/-) mice exhibit an increased transepidermal water loss, and we show that the hepatic phenotype is caused specifically by the epidermal barrier defect, which leads to increased lipolysis in white adipose tissue. Our data demonstrate that an imperfect epidermal barrier leads to profound suppression of the hepatic SREBP gene program and lipid accumulation in the liver.